Your institution may have access to this item. Find your institution then sign in to continue.
Title
A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma.
Authors
Ko AH; Youssoufian H; Gurtler J; Dicke K; Kayaleh O; Lenz HJ; Keaton M; Katz T; Ballal S; Rowinsky EK
Publication
Investigational new drugs, 2012, Vol 30, Issue 4, p1597